Common behavioral problems among children with asthma: Is there a role of asthma treatment?

Annals of Allergy, Asthma and Immunology

Volumn 106, Issue 3, 2011, Pages 200-204

  Saricoban, Hulya Ercan ^a   Ozen, Ahmet ^a   Harmanci, Koray ^b   Razi, Cem ^b   Zahmacioglu, Oguzhan ^a   Cengizlier, Mehmet Reha ^a  

^a YEDITEPE UNIVERSITY   (Turkey)

^b OSMANGAZI UNIVERSITY MEDICAL FACULTY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; LEUKOTRIENE RECEPTOR BLOCKING AGENT;

ADOLESCENT; ARTICLE; ASTHMA; ATTENTION DEFICIT DISORDER; CHILD; CHILD BEHAVIOR; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; HYPERACTIVITY; IMPULSIVENESS; MAJOR CLINICAL STUDY; MALE; OPPOSITIONAL DEFIANT DISORDER; PATIENT ASSESSMENT; PRIORITY JOURNAL; SCHOOL CHILD; TREATMENT DURATION;

ANTI-ASTHMATIC AGENTS; ASTHMA; CHILD; CHILD BEHAVIOR DISORDERS; FEMALE; GLUCOCORTICOIDS; HUMANS; LEUKOTRIENE ANTAGONISTS; MALE; STATISTICS, NONPARAMETRIC;

EID: 79952194388     PISSN: 10811206     EISSN: 15344436     Source Type: Journal    
DOI: 10.1016/j.anai.2010.11.016     Document Type: Article

References (24)

1. Scott KM, Von Korff M, Ormel J, et al. Mental disorders among adults with asthma: results from the World Mental Health Survey. Gen Hosp Psychiatry. 2007;29:123-133. (Pubitemid 46343650)
2. Chun TH, Weitzen SH, Fritz GK. The asthma/mental health nexus in a population-based sample of the United States. Chest. 2008;134:1176-1182.
3. Blackman JA, Gurka MJ. Developmental and behavioral comorbidities of asthma in children. J Dev Behav Pediatr. 2007;28:92-99. (Pubitemid 46624833)
4. White MV, Sander N. Asthma from the perspective of the patient. J Allergy Clin Immunol. 1999;104:547-552.
5. Rachelefsky GS, Wo J, Adelson J, et al. Behavior abnormalities and poor school performance due to oral theophylline use. Pediatrics. 1986;78:1133-1138. (Pubitemid 17190258)
6. Stein MA, Lerner CA. Behavioral and cognitive effect of theophylline: a dose-response study. Ann Allergy. 1993;70:135-140. (Pubitemid 23062808)
7. Bender B, Zhang L. Negative affect, medication adherence, and asthma control in children. J Allergy Clin Immunol. 2008;122:490-495.
8. Wainwright NW, Surtees PG, Wareham NJ, Harrison BD. Psychosocial factors and incident asthma hospital admissions in the EPIC-Norfolk cohort study. Allergy. 2007;62:554-560. (Pubitemid 46608357)
9. Campbell DA, Yellowlees PM, McLennan G, et al. Psychiatric and medical features of near fatal asthma. Thorax. 1995;50:254-259.
10. Global Strategy for Asthma Management and Prevention Global Initiative for Asthma (GINA) 2006.
11. Turgay A. Çocuk ve Ergenlerde Davranim Bozukluklari için DSM-IV'e Dayali Tarama ve De.gerlendirme Ölçe.gi (yayinlanmamiş ölçek), Integrative Therapy Institute Toronto, Canada, 1995.
12. Ercan ES, Amado S, Somer O, Çiko.glu S. Dikkat eksikli.gi ve hiperaktivite bozuklu.gu ve yikici davranim bozukluklari için bir test bataryasi geliştirme çabasi. Çocuk ve Gençlik Ruh Sa.gli.gi Dergisi. 2005;8:132-142.
13. Fowler MG, Davenport MG, Garg R. School functioning of US children with asthma. Pediatrics. 1992;90:939-944.
14. Escobar R, Soutullo CA, Hervas A, Gastaminza X, Polavieja P, Gilaberte I. Worse quality of life for children with newly diagnosed attentiondeficit/ hyperactivity disorder, compared with asthmatic and healthy children. Pediatrics. 2005;116:e364-369.
15. Stein MA, Lerner CA. Behavioral and cognitive effect of theophylline: a dose-response study. Ann Allergy. 1993;70:135-140. (Pubitemid 23062808)
16. Yuksel H, Sogut A,Yilmaz O. Attention deficit and hyperactivity symptoms in children with asthma. J Asthma. 2008;45:545-547.
17. Hederos CA. Neuropsychologic changes and inhaled corticosteroids. J Allergy Clin Immunol. 2004;114:451-452.
18. de Vries TW, van Roon EN, Duiverman EJ. Inhaled corticosteroids do not affect behaviour. Acta Paediatr. 2008:97;786-789. (Pubitemid 351652454)
19. Smith NA, Seale JP, Shaw J. Medication compliance in children with asthma. Aust Paediatr J. 1984;20:47-51. (Pubitemid 14123236)
20. Spector SL, Kinsman R, Mawhinney H, et al. Compliance of patients with asthma with an experimental aerosolized medication: implications for controlled clinical trials. J Allergy Clin Immunol. 1986;77:65-70. (Pubitemid 16127387)
21. Ferguson AE, Gibson NA, Aitchison TC, Paton JY. Measured bronchodilator use in preschool children with asthma. BMJ. 1995;310:1161-1164.
22. Singulair (montelukast sodium) prescribing information [package insert]. Whitehouse Station (NJ): Merck & Co, Inc., 2009.
23. Wallerstedt SM, Brunlöf G, Sundström A, et al. Montelukast and psychiatric disorders in children. Pharmacoepidemiol Drug Saf. 2009;18:858-864.
24. Philip G, Hustad CM, Malice MP, Noonan G, Ezekowitz A, Reiss TF, Knorr B. Analysis of behavior-related adverse experiences in clinical trials of montelukast. J Allergy Clin Immunol. 2009;124:699-706.